Deutsche Bank AG Raises Position in Molina Healthcare, Inc. (NYSE:MOH)

Deutsche Bank AG lifted its position in Molina Healthcare, Inc. (NYSE:MOH) by 12.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 338,460 shares of the company’s stock after buying an additional 37,941 shares during the period. Deutsche Bank AG owned about 0.59% of Molina Healthcare worth $98,509,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its position in Molina Healthcare by 3.3% in the 3rd quarter. Principal Financial Group Inc. now owns 74,160 shares of the company’s stock worth $25,553,000 after buying an additional 2,389 shares during the last quarter. Nordea Investment Management AB grew its stake in shares of Molina Healthcare by 7.2% in the fourth quarter. Nordea Investment Management AB now owns 4,445 shares of the company’s stock worth $1,300,000 after acquiring an additional 300 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Molina Healthcare by 4.9% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 2,838 shares of the company’s stock valued at $826,000 after purchasing an additional 132 shares during the last quarter. Czech National Bank lifted its position in Molina Healthcare by 3.9% during the fourth quarter. Czech National Bank now owns 12,403 shares of the company’s stock valued at $3,610,000 after purchasing an additional 466 shares during the period. Finally, Pallas Capital Advisors LLC boosted its holdings in Molina Healthcare by 132.9% in the fourth quarter. Pallas Capital Advisors LLC now owns 2,059 shares of the company’s stock worth $599,000 after purchasing an additional 1,175 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on MOH. Wells Fargo & Company upgraded shares of Molina Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Mizuho upped their price objective on Molina Healthcare from $376.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Truist Financial raised their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Baird R W lowered shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Finally, Barclays increased their price objective on shares of Molina Healthcare from $339.00 to $362.00 and gave the stock an “equal weight” rating in a research note on Friday, April 25th. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Molina Healthcare has an average rating of “Hold” and an average target price of $365.38.

Insiders Place Their Bets

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares in the company, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the firm’s stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company’s stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. Insiders sold 89,169 shares of company stock worth $28,520,995 in the last three months. 1.10% of the stock is owned by company insiders.

Molina Healthcare Trading Down 0.6%

Shares of MOH stock opened at $323.84 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock has a fifty day simple moving average of $324.73 and a two-hundred day simple moving average of $308.38. The firm has a market capitalization of $17.55 billion, a PE ratio of 15.85, a PEG ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analysts’ expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the business posted $5.73 earnings per share. On average, analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.